Sos Covid

The effect of ALFALIFE™ in reducing the Low-Grade Inflammation

ISRCTN Registry

Interventional study to verify the efficacy of ALFALIFE™ administration in potentiating the effects of diet in patients with low-grade inflammation, and its associate conditions as prediabetes, diabetes, overweight and inflammatory response to viral infections.

The effect of ALFALIFE™ in improving the metabolic syndrome and in reducing the Low-Grade Inflammation

Ongoing recording on ISRCTN registry

Interventional study to verify if ALFALIFE™ as supplementation of a healthy diet modifies, in adult patients:
a) the content of Alpha Linolenic Acid in red blood cells
b) the circulating levels of prostanoids related to inflammation, thrombosis, atherosclerosis
c) the other metabolic hearth diseases risk-factors

Skip to content